Absology
PrivateLast Round
Series B
Extension
Dec 21, 2023
Total Funding Raised
$24.92M
Company Overview
Absology operates in Healthcare & Life Sciences and is based in Anyang-si. Its latest recorded funding round was a Series B Extension round in December 2023.
Absology is a medical diagnostics company that develops and manufactures in vitro immunodiagnostic medical devices and microfluidic immunoassay technologies.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotech Equipment, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales, Subscription SaaS
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Absology Comparables
Compare Absology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Micropoint Biotechnologies | 81% | |
| Optolane | 80% | |
| Boditech Med Inc. | 80% |
For institutional investors. Book with your work email.
Absology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Dec 21, 2023 | ||||
| Series B | May 25, 2022 |
For institutional investors. Book with your work email.
Absology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Premier Partners | Series B |
| Forest Ventures | Series B Extension |
| Korea Development Bank | Series B Extension |
| InterValue Partners | Series B |
| Forest Partners | Series B Extension |
| Krossroad Partners | Series B, Series B Extension |
| Industrial Bank of Korea | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 7, 2026
Monthly visitors increased 957% MoM, reaching 2.5K.
- Dec 21, 2023
Raised $7.68M from Forest Partners and others.
For institutional investors. Book with your work email.
Absology Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Absology's valuation, stock price, and market status.
Is Absology a public or private company?
Absology is a private company.
What is the current stock price of Absology?
Absology is a private company, so its shares have no public market price. Caplight tracks Absology's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Absology worth (valuation)?
Valuation information for Absology is not publicly available.
Can I buy Absology stock?
Absology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Absology's last funding round?
Absology's most recent funding round was Series B Extension on December 21, 2023.
Who are the main investors in Absology?
Key investors in Absology include Premier Partners, Forest Ventures, Korea Development Bank, InterValue Partners, Forest Partners.
Will Absology IPO soon?
No public IPO plans have been announced for Absology.
How can I track Absology secondary market activity?
Caplight tracks bids, offers, and trades in Absology's shares on secondary markets.